PDS Biotechnology (NasdaqCM:PDSB) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Company ParticipantsFrank Bedu-Addo - CEOKirk Shepard - CMOLars Boesgaard - CFOMayank Mamtani - Senior Managing DirectorMike Moyer - Managing DirectorConference Call ParticipantsJosh Korsen - AnalystOperatorGreetings, and welcome to the PDS Biotechnology fourth quarter 2025 earnings call. At this time, all participants are in listen-only mode. A question and answer session will follow the formal presentation. If anyone should ...

Neumora Therapeutics (NasdaqGS:NMRA) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Company ParticipantsAlyssa Larios - Company RepresentativeBill Aurora - Chief Operating and Development OfficerBrian Abrahams - Global Managing Director and Sector Head of Healthcare ResearchDouglas Tsao - Managing Director of Equity ResearchHelen Rubinstein - VP of Investor Relations and Corporate StrategyJosh Pinto - PresidentJulian Pino - Biotechnology Equity Research Senior AssociateMike Milligan - CFONick Brandon - Ch ...

Viridian Therapeutics (NasdaqCM:VRDN) Update / briefing March 30, 2026 08:00 AM ET Company ParticipantsAlex Thompson - Research Managing Director of Biotech Equity ResearchFaisal Khurshid - Managing Director of Equity ResearchGavin Clark-Gartner - Managing Director of Biotechnology Equity ResearchGreg Rossino - Senior Director of Investor RelationsGregory Renza - Managing DirectorJason Butler - Managing DirectorLaura Chico - Managing DirectorLisa Walter - VPRadhika Tripuraneni - Chief Medical OfficerShan Wu ...

CBAK Energy Technology (NasdaqCM:CBAT) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Speaker4Good day, ladies and gentlemen. Thank you for standing by, and welcome to CBAK Energy Technology's fourth quarter and full year 2025 earnings conference call. Currently, all participants are in listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. As a reminder, we are recording today's call. If you have any objections, you may disconnect at this time. ...

PDS Biotechnology (NasdaqCM:PDSB) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Speaker6Greetings, and welcome to the PDS Biotechnology fourth quarter 2025 earnings call. At this time, all participants are in listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn the conference over to ...

SEB (OTCPK:SVKE.F) Update / briefing March 30, 2026 08:00 AM ET Company ParticipantsPawel Wyszynski - Head of Investor RelationsConference Call ParticipantsNone - AnalystNone - AnalystNone - AnalystNone - AnalystNone - AnalystNone - AnalystPawel WyszynskiOkay, I believe we've reached some kind of critical mass, so I'll kick off. Welcome to SEB's Q1 2026 pre-close call. My name is Pawel Wyszynski, and I work in the Investor Relations team here at SEB. This call is being recorded. The script used will be publ ...

Neumora Therapeutics (NasdaqGS:NMRA) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Speaker9Ladies and gentlemen, thank you for standing by. At this time, all participants are in a listen-only mode. After the speaker's presentation, there'll be a question and answer session. Please be advised that today's conference is being recorded. I would now like to turn the call over to Helen Rubenstein, Vice President of Investor Relations and Corporate Strategy at Neumora. Please go ahead.Speaker4Good afternoon, a ...

Sigma Lithium (NasdaqCM:SGML) Q4 2025 Earnings call March 30, 2026 07:30 AM ET Company ParticipantsAna Cabral - Co-Chair and CEOAnna Hartley - VP of Investor RelationsModeratorGood morning, ladies and gentlemen. Welcome to Sigma Lithium's 2025 fourth-quarter earnings conference call. We would like to inform you that this event is being recorded, and all participants will be in a listen-only mode during the company's presentation. There will be a replay for this call on the company's website. After the prepa ...

Sigma Lithium (NasdaqCM:SGML) Q4 2025 Earnings call March 30, 2026 07:30 AM ET Company ParticipantsAna Cabral - Co-Chair and CEOAnna Hartley - VP of Investor RelationsModeratorGood morning, ladies and gentlemen. Welcome to Sigma Lithium's 2025 fourth quarter earnings conference call. We would like to inform you that this event is being recorded and all participants will be in a listen-only mode during the company's presentation. There will be a replay for this call on the company's website. After the prepar ...

Sigma Lithium (NasdaqCM:SGML) Q4 2025 Earnings call March 30, 2026 07:30 AM ET Speaker2 Good morning, ladies and gentlemen. Welcome to Sigma Lithium's 2025 fourth quarter earnings conference call. We would like to inform you that this event is being recorded and all participants will be in a listen-only mode during the company's presentation. There will be a replay for this call on the company's website. After the prepared remarks, there will be a question and answer session for all participants. At that ti ...